Pages changed: GLP-Agonists and Insulin for Type 2 Diabetes
Brief mention made of the upcoming approval of semaglutide, the first GLP-1 agonist in pill form and of Fiasp, a new fast-acting insulin which is similar to Apidra in that it can be injected just after eating and still be effective.
Wednesday, October 18, 2017
Subscribe to:
Posts (Atom)
